Existence of Compensatory Defense Mechanisms Against Oxidative Stress and Hypertension in Preeclampsia

REFERENCES

• Bilodeau JF, Hubel CA. Current concepts in the use of antioxidants for the treatment of preeclampsia. J Obstet Gynaecol Can 2003; 25:742–750.
   PubMedGoogle Scholar
• Roberts JM, Speer P. Antioxidant therapy to prevent preeclampsia. Semin Nephrol 2004; 24:557–564.
   PubMed Web of Science ®Google Scholar
• Teran E, Racines-Orbe M, Vivero S, Escudero C, Molina G, Calle A. Preeclampsia is associated with a decrease in plasma coenzyme Q10 levels. Free Radic Biol Med 2003; 35:1453–1456.
   PubMed Web of Science ®Google Scholar
• Helewa ME, Burrows RF, Smith J, Williams K, Brain P, Rabkin SW. Report of the Canadian Hypertension Society Consensus Conference: 1. Definitions, evaluation and classification of hypertensive disorders in pregnancy. CMAJ 1997; 157:715–725.
   PubMed Web of Science ®Google Scholar
• Hubel CA. Oxidative stress in the pathogenesis of preeclampsia. Proc Soc Exp Biol Med 1999; 222:222–235.
   PubMed Web of Science ®Google Scholar
• Hubel CA. Dyslipidemia, iron, and oxidative stress in preeclampsia: assessment of maternal and feto-placental interactions. Semin Reprod Endocrinol 1998; 16:75–92.
   PubMedGoogle Scholar
• Hubel CA, Lyall F, Weissfeld L, Gandley RE, Roberts JM. Small low-density lipoproteins and vascular cell adhesion molecule-1 are increased in association with hyperlipidemia in preeclampsia. Metabolism 1998; 47:1281–1288.
   PubMed Web of Science ®Google Scholar
• Luo ZC, Fraser WD, Julien P, Deal CL, Audibert F, Smith GN, Xiong X, Walker M. Tracing the origins of “fetal origins” of adult diseases: programming by oxidative stress? Med Hypothes 2006; 66:38–44.
   PubMed Web of Science ®Google Scholar
• McKinney ET, Shouri R, Hunt RS, Ahokas RA, Sibai BM. Plasma, urinary, and salivary 8-epi-prostaglandin f2alpha levels in normotensive and preeclamptic pregnancies. Am J Obstet Gynecol 2000; 183:874–877.
   PubMed Web of Science ®Google Scholar
• Chappell LC, Seed PT, Briley AL, Kelly FJ, Lee R, Hunt BJ, Parmar K, Bewley SJ, Shennan AH, Steer PJ, Poston L. Effect of antioxidants on the occurrence of pre-eclampsia in women at increased risk: a randomised trial. Lancet 1999; 354:810–816.
   PubMed Web of Science ®Google Scholar
• Chappell LC, Seed PT, Kelly FJ, Briley A, Hunt BJ, Charnock-Jones DS, Mallet A, Poston L. Vitamin C and E supplementation in women at risk of preeclampsia is associated with changes in indices of oxidative stress and placental function. Am J Obstet Gynecol 2002; 187:777–784.
   PubMed Web of Science ®Google Scholar
• Poston L, Raijmakers M, Kelly F. Vitamin E in preeclampsia. Ann N Y Acad Sci 2004; 1031:242–248.
   PubMedGoogle Scholar
• Polyzos NP, Mauri D, Tsappi M, Tzioras S, Kamposioras K, Cortinovis I, Casazza G. Combined vitamin C and E supplementation during pregnancy for preeclampsia prevention: a systematic review. Obstet Gynecol Surv 2007; 62:202–206.
   PubMed Web of Science ®Google Scholar
• Poston L, Briley AL, Seed PT, Kelly FJ, Shennan AH. Vitamin C and vitamin E in pregnant women at risk for pre-eclampsia (VIP trial): randomised placebo-controlled trial. Lancet 2006;367:1145–1154.
   PubMed Web of Science ®Google Scholar
• Lagendijk J, Ubbink JB, Vermaak WJ. Measurement of the ratio between the reduced and oxidized forms of coenzyme Q10 in human plasma as a possible marker of oxidative stress. J Lipid Res 1996; 37:67–75.
   PubMed Web of Science ®Google Scholar
• Banerjee S, Chambers AE, Campbell S. Is vitamin E a safe prophylaxis for preeclampsia? Am J Obstet Gynecol 2006; 194:1228–1233.
   PubMed Web of Science ®Google Scholar
• Finckh B, Kontush A, Commentz J, Hubner C, Burdelski M, Kohlschutter A. Monitoring of ubiquinol-10, ubiquinone-10, carotenoids, and tocopherols in neonatal plasma microsamples using high-performance liquid chromatography with coulometric electrochemical detection. Anal Biochem 1995; 232:210–216.
   PubMedGoogle Scholar
• Stocker R, Bowry VW, Frei B. Ubiquinol-10 protects human low density lipoprotein more efficiently against lipid peroxidation than does alpha-tocopherol. Proc Natl Acad Sci U S A 1991; 88:1646–1650.
   PubMed Web of Science ®Google Scholar
• Yalcin A, Kilinc E, Sagcan A, Kultursay H. Coenzyme Q10 concentrations in coronary artery disease. Clin Biochem 2004; 37:706–709.
   PubMed Web of Science ®Google Scholar
• Stoyanovsky DA, Osipov AN, Quinn PJ, Kagan VE. Ubiquinone-dependent recycling of vitamin E radicals by superoxide. Arch Biochem Biophys 1995; 323:343–351.
   PubMed Web of Science ®Google Scholar
• Chavarria ME, Lara-Gonzalez L, Gonzalez-Gleason A, Garcia-Paleta Y, Vital‐Reyes VS, Reyes A. Prostacyclin/thromboxane early changes in pregnancies that are complicated by preeclampsia. Am J Obstet Gynecol 2003; 188:986–992.
   PubMedGoogle Scholar
• Kaaja RJ, Moore MP, Yandle TG, Ylikorkala O, Frampton CM, Nicholls MG. Blood pressure and vasoactive hormones in mild preeclampsia and normal pregnancy. Hypertens Pregnancy 1999; 18:173–187.
   PubMed Web of Science ®Google Scholar
• Nishimaki S, Seki K. An imbalance between prostacyclin and thromboxane in relation to cerebral blood flow in neonates with maternal preeclampsia. Prostaglandins Other Lipid Mediat 1999; 58:43–49.
   PubMedGoogle Scholar
• Mills JL, DerSimonian R, Raymond E, Morrow JD, Roberts LJ, 2nd, Clemens JD, Hauth JC, Catalano P, Sibai B, Curet LB, Levine RJ. Prostacyclin and thromboxane changes predating clinical onset of preeclampsia: a multicenter prospective study. JAMA 1999; 282:356–362.
   PubMed Web of Science ®Google Scholar
• Paarlberg KM, de Jong CL, van Geijn HP, van Kamp GJ, Heinen AG, Dekker GA. Vasoactive mediators in pregnancy-induced hypertensive disorders: a longitudinal study. Am J Obstet Gynecol 1998; 179:1559–1564.
   PubMedGoogle Scholar
• Kraayenbrink AA, Dekker GA, van Kamp GJ, van Geijn HP. Endothelial vasoactive mediators in preeclampsia. Am J Obstet Gynecol 1993; 169:160–165.
   PubMed Web of Science ®Google Scholar
• Walsh SW, Wang Y. Deficient glutathione peroxidase activity in preeclampsia is associated with increased placental production of thromboxane and lipid peroxides. Am J Obstet Gynecol 1993; 169:1456–1461.
   PubMed Web of Science ®Google Scholar
• Chavarria Olarte ME, Gonzalez Gleason A, Lara Gonzalez AL, Sojo Aranda I, Garcia Paleta Y, Vital Reyes VS, Reyes Fuentes A. [Plasma concentration of biochemical markers in pre-eclampsia-eclampsia and its association with the severity of the disease]. Ginecol Obstet Mex 2000; 68:385–393.
   PubMedGoogle Scholar
• Goeschen K, Henkel E, Behrens O. Plasma prostacyclin and thromboxane concentrations in 160 normotensive, hypotensive, and preeclamptic patients during pregnancy, delivery, and the post partum period. J Perinat Med 1993; 21:481–489.
   PubMedGoogle Scholar
• Wang YP, Walsh SW, Guo JD, Zhang JY. The imbalance between thromboxane and prostacyclin in preeclampsia is associated with an imbalance between lipid peroxides and vitamin E in maternal blood. Am J Obstet Gynecol 1991; 165:1695–1700.
   PubMed Web of Science ®Google Scholar
• Furuhashi N, Tsujiei M, Kimura H, Yajima A, Kimura C, Ide Y. Plasma renin activity, angiotensin II, prostacyclin and thromboxane A2 concentrations in 139 preeclamptic patients. Tohoku J Exp Med 1990; 162:235–241.
   PubMedGoogle Scholar
• Davidge ST. Oxidative stress and altered endothelial cell function in preeclampsia. Semin Reprod Endocrinol 1998; 16:65–73.
   PubMedGoogle Scholar
• Walsh SW. Eicosanoids in preeclampsia. Prostaglandins Leukot Essent Fatty Acids 2004; 70:223–232.
   PubMed Web of Science ®Google Scholar
• Chen G, Kamal M, Hannon R, Warner TD. Regulation of cyclo-oxygenase gene expression in rat smooth muscle cells by catalase. Biochem Pharmacol 1998; 55:1621–1631.
   PubMedGoogle Scholar
• Margalit A, Hauser SD, Zweifel BS, Anderson MA, Isakson PC. Regulation of prostaglandin biosynthesis in vivo by glutathione. Am J Physiol 1998; 274:R294–302.
   Google Scholar
• Mahomed K, Williams MA, King IB, Mudzamiri S, Woelk GB. Erythrocyte omega-3, omega-6 and trans fatty acids in relation to risk of preeclampsia among women delivering at Harare Maternity Hospital, Zimbabwe. Physiol Res 2007; 56:37–50.
   PubMed Web of Science ®Google Scholar
• Levesque S, Moutquin JM, Lindsay C, Roy MC, Rousseau F. Implication of an AGT haplotype in a multigene association study with pregnancy hypertension. Hypertension 2004; 43:71–78.
   PubMed Web of Science ®Google Scholar
• Shaikh NA, Downar E. Time course of changes in porcine myocardial phospholipid levels during ischemia. A reassessment of the lysolipid hypothesis. Circ Res 1981; 49:316–325.
   PubMed Web of Science ®Google Scholar
• Lepage G, Roy CC. Direct transesterification of all classes of lipids in a one-step reaction. J Lipid Res 1986; 27:114–120.
   PubMed Web of Science ®Google Scholar
• Podda M, Weber C, Traber MG, Packer L. Simultaneous determination of tissue tocopherols, tocotrienols, ubiquinols, and ubiquinones. J Lipid Res 1996; 37:893–901.
   PubMed Web of Science ®Google Scholar
• Menke T, Niklowitz P, Adam S, Weber M, Schluter B, Andler W. Simultaneous detection of ubiquinol-10, ubiquinone-10, and tocopherols in human plasma microsamples and macrosamples as a marker of oxidative damage in neonates and infants. Anal Biochem 2000; 282:209–217.
   PubMed Web of Science ®Google Scholar
• Lang JK, Gohil K, Packer L. Simultaneous determination of tocopherols, ubiquinols, and ubiquinones in blood, plasma, tissue homogenates, and subcellular fractions. Anal Biochem 1986;157:106–116.
   PubMed Web of Science ®Google Scholar
• Croft KD, Beilin LJ, Vandongen R, Mathews E. Dietary modification of fatty acid and prostaglandin synthesis in the rat. Effect of variations in the level of dietary fat. Biochim Biophys Acta 1984; 795:196–207.
   PubMed Web of Science ®Google Scholar
• Patten GS, Adams MJ, Dallimore JA, Abeywardena MY. Depressed prostanoid-induced contractility of the gut in spontaneously hypertensive rats (SHR) is not affected by the level of dietary fat. J Nutr 2004; 134:2924–2929.
   PubMedGoogle Scholar
• Uotila JT, Tuimala RJ, Aarnio TM, Pyykko KA, Ahotupa MO. Findings on lipid peroxidation and antioxidant function in hypertensive complications of pregnancy. Br J Obstet Gynaecol 1993; 100:270–276.
   PubMedGoogle Scholar
• Schiff E, Friedman SA, Stampfer M, Kao L, Barrett PH, Sibai BM. Dietary consumption and plasma concentrations of vitamin E in pregnancies complicated by preeclampsia. Am J Obstet Gynecol 1996; 175:1024–1028.
   PubMed Web of Science ®Google Scholar
• Jendryczko A, Drozdz M. Plasma retinol, beta-carotene and vitamin E levels in relation to the future risk of pre-eclampsia. Zentralbl Gynakol 1989; 111:1121–1123.
   PubMedGoogle Scholar
• Williams MA, Woelk GB, King IB, Jenkins L, Mahomed K. Plasma carotenoids, retinol, tocopherols, and lipoproteins in preeclamptic and normotensive pregnant Zimbabwean women. Am J Hypertens 2003; 16:665–672.
   PubMed Web of Science ®Google Scholar
• Zhang C, Williams MA, Sanchez SE, King IB, Ware-Jauregui S, Larrabure G, Bazul V, Leisenring WM. Plasma concentrations of carotenoids, retinol, and tocopherols in preeclamptic and normotensive pregnant women. Am J Epidemiol 2001; 153:572–580.
   PubMed Web of Science ®Google Scholar
• Thomas SR, Witting PK, Stocker R. A role for reduced coenzyme Q in atherosclerosis? Biofactors 1999; 9:207–224.
   PubMed Web of Science ®Google Scholar
• Yamashita S, Yamamoto Y. Simultaneous detection of ubiquinol and ubiquinone in human plasma as a marker of oxidative stress. Anal Biochem 1997; 250:66–73.
   PubMed Web of Science ®Google Scholar
• Kontush A, Hubner C, Finckh B, Kohlschutter A, Beisiegel U. Antioxidative activity of ubiquinol-10 at physiologic concentrations in human low density lipoprotein. Biochim Biophys Acta 1995; 1258:177–187.
   PubMedGoogle Scholar
• Ostlund I, Haglund B, Hanson U. Gestational diabetes and preeclampsia. Eur J Obstet Gynecol Reprod Biol 2004; 113:12–16.
   PubMed Web of Science ®Google Scholar
• Udvardy M, Torok I, Rak K. Plasma thromboxane and prostacyclin metabolite ratio in atherosclerosis and diabetes mellitus. Thromb Res 1987; 47:479–484.
   PubMedGoogle Scholar
• Ylikorkala O, Kaila J, Viinikka L. Prostacyclin and thromboxane in diabetes. Br Med J (Clin Res Ed) 1981; 283:1148–1150.
   PubMedGoogle Scholar
• Numano F, Omori K, Nishiyama K, Kishi Y, Shimokado K, Numano F, Yajima M, Maezawa H. Plasma thromboxane B2 levels and atherosclerotic disorders. Paroi Arterielle 1981; 7:99–105.
   PubMedGoogle Scholar
• Khasawneh FT, Huang JS, Mir F, Srinivasan S, Tiruppathi C, Le Breton GC. Characterization of isoprostane signaling: Evidence for a unique coordination profile of 8-iso-PGF(2alpha) with the thromboxane A(2) receptor, and activation of a separate cAMP-dependent inhibitory pathway in human platelets. Biochem Pharmacol 2008, 75:2301–2315.
   PubMed Web of Science ®Google Scholar